The decision follows the 2008 U.S. Supreme Court ruling in Riegel vs. Medtronic, stating that the FDA 510(k) approval of a medical device preempts state law, and product liability lawsuits based on state tort laws have no standing, according to the report.
Stryker has won previous lawsuits regarding the Trident hip implant.
Read the Mass Device news report on the court’s decision.
Read other coverage on Stryker:
– Stryker’s David Veino: In Support of Vertebroplasty
– Stryker Acquires Gaymar Industry
– Stryker Receives Two Subpoenas for Device Marketing
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
